Prediction and characterisation of the human B cell response to a heterologous two-dose Ebola vaccine.

In the scRNA-seq data, a nominally significant decrease in proliferating B cells (unadjusted p -value < 0.05) was also observed when comparing baseline samples with aggregated post-vaccination data (Fig. 5e ).

also in 7,732 other papers